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CAPSULE 
Background. Assembly of cytochrome c 
oxidase (COX), complex IV of the respiratory 
chain, requires a great number of accessory 
proteins known as assembly factors. 
Results. hCOA3 interacts with newly 
synthesized COX1 and promotes its assembly 
with subsequent COX subunits. 
Conclusion. hCOA3 participates in COX 
biogenesis in humans. 
Significance. hCOA3 is a new candidate gene 
to screen in patients with COX deficiency. 
 
 ABSTRACT 
Cytochrome c oxidase (COX) or complex 
IV of the mitochondrial respiratory chain 
plays a fundamental role in energy 
production of aerobic cells. In humans, 
COX deficiency is the most frequent cause 
of mitochondrial encephalomyopathies. 
Human COX is composed of 13 subunits of 
dual genetic origin, whose assembly 
requires an increasing number of nuclear-
encoded accessory proteins known as 
assembly factors. Here, we have identified 
and characterized human CCDC56, an 
11.7 KDa mitochondrial transmembrane 
protein, as a new factor essential for COX 
biogenesis. CCDC56 shares sequence 
similarity with the yeast COX assembly 
factor Coa3 and was termed hCOA3. 
hCOA3-silenced cells display a severe COX 
functional alteration owing to a decreased 
stability of newly synthesized COX1 and 
an impairment in the holoenzyme assembly 
process. We show that hCOA3 physically 
interacts with both the mitochondrial 
translation machinery and COX structural 
subunits. We conclude that hCOA3 
stabilizes COX1 co-translationally and 
promotes its assembly with COX partner 
subunits. Finally, our results identify 
hCOA3 as a new candidate when screening 
for genes responsible for mitochondrial 
diseases associated with COX deficiency. 
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INTRODUCTION 
Mitochondria produce most cellular 
ATP by the process of oxidative 
phosphorylation (OXPHOS) carried out by 
the four complexes of the respiratory chain 
and the F1F0 ATPase. Cytochrome c oxidase 
(COX) or complex IV, the terminal enzyme 
of the respiratory chain, catalyzes the 
oxidation of cytochrome c by transferring its 
electrons to molecular oxygen (1). 
Mammalian complex IV is composed of 13 
subunits. Three subunits forming the catalytic 
core, COX1, COX2 and COX3, are encoded 
in the mitochondrial DNA (mtDNA), while 
the remaining ten subunits (COX4, COX5a, 
COX5b, COX6a, COX6b, COX6c, COX7a, 
COX7b, COX7c, and COX8) are encoded in 
the nuclear genome (2,3). The enzyme 
contains four redox-active metal centers: two 
iron centers, heme a and heme a3, and two 
copper centers, CuA and CuB, which are 
essential for its assembly and function (4).  
COX assembly is thought to be a 
linear process in which its subunits and 
cofactors are incorporated in an ordered 
manner (5). More than 30 COX assembly 
factors have been identified in model 
organisms, mainly the yeast Saccharomyces 
cerevisiae, and in human patients with COX 
deficiencies. They are required for every step 
of the formation of the complex, from 
translation of the individual subunits to 
incorporation of the prosthetic groups and 
assembly of the holoenzyme (6). COX 
biogenesis must be tightly regulated to 
prevent the accumulation of pro-oxidant 
assembly intermediates. We and others have 
recently shown that in S. cerevisiae there is a 
negative feedback translational regulatory 
system that serves to coordinate the synthesis 
in mitochondrial ribosomes of COX1 a 
subunit containing heme a and copper 
centers, with its assembly into the 
holoenzyme (6,7). The mechanism involves 
Mss51, a translational activator that 
additionally acts as a COX1 chaperone, as 
well as Cox14 and Coa3, two COX1 
stability/assembly factors. Whether this 
regulatory mechanism is conserved in humans 
remains to be fully disclosed. 
In recent years, COX biogenesis 
gained much interest because defects in the 
assembly of the enzyme are a major cause of 
mitochondrial disorders in humans and may 
play an important role in aging and 
degenerative diseases (8-10). In fact, COX 
deficiency is one of the most frequent causes 
of mitochondrial encephalomyopathies in 
humans (11). Mutations in the three mtDNA-
encoded COX subunits and nuclear-encoded 
subunits COX4, COX6b and COX7b have 
been identified in patients (12-17), although 
these defects are relatively rare. Most COX 
deficiencies described to date are caused by 
mutations in assembly factors (8,11). 
However, in the majority of patients, the 
molecular basis of their autosomal recessive 
COX deficiency remains unknown. Although 
the list of COX assembly genes identified in 
yeast is likely close to completion, identifying 
the respective human homologues is not 
simple in some cases due to their divergent 
primary sequences. Recent studies based on 
iterative orthology prediction have identified 
new human homologues of yeast COX 
assembly factors (18). Among them are some 
key proteins involved in the COX assembly 
regulatory process described earlier (Cox14, 
Coa3 and Mss51) which suggests that such a 
regulatory mechanism could actually exist in 
human cells. Notably, mutations in C12orf62, 
the human homologue of yeast Cox14, have 
been recently shown to produce COX 
deficiency in a patient with severe congenital 
lactic acidosis (19). C12orf62 was proposed 
to couple COX1 synthesis and cytochrome c 
oxidase assembly as its yeast counterpart 
(19). 
We have recently identified a 
mitochondrial protein in Drosophila 
melanogaster, CCDC56, encoded on a 
bicistronic mRNA with mitochondrial 
translation factor B1 (mtTFB1) (20). This 
protein is essential for COX activity in 
Drosophila and is highly conserved 
throughout evolution. It has recently become 
evident that CCDC56 is actually the fly 
homologue of yeast Coa3. Here we 
demonstrate that human CCDC56, hereafter 
termed hCOA3, is involved in the early steps 
of COX biogenesis by securing the stability 
and promoting the assembly of newly 
synthesized COX1. These results suggest that 
hCOA3 could play a role in coordinating 
COX1 synthesis and assembly. Finally, our 
results identify hCOA3 as a new candidate 
when screening for genes responsible for 
mitochondrial diseases associated with COX 
deficiency.  
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RESULTS 
hCOA3 is a transmembrane protein of the 
inner mitochondrial membrane 
We have recently shown CCDC56 to 
be a mitochondrial protein essential for COX 
activity in D. melanogaster (20), although its 
precise function remained to be elucidated. 
BLAST alignments showed this protein is 
well conserved from Drosophila to humans 
and more recent studies have suggested 
CCDC56 is the homologue of yeast Coa3 
(18). Human COA3, is located on 
chromosome 17 (17q.21.31) and encodes an 
11.7 KDa protein with predicted 
transmembrane and coiled-coil domains. 
To analyze whether hCOA3 is a 
mitochondrial protein as described for its D. 
melanogaster orthologue (20), we 
overexpressed a C-terminal FLAG-tagged 
version of the protein in HeLa cells. 
Immunocytochemical experiments showed 
this protein to be localized exclusively to 
mitochondria (Fig 1A). Sonication of 
mitochondria followed by centrifugation to 
separate soluble and insoluble proteins 
showed hCOA3-FLAG behaves as a 
mitochondrial membrane protein (Fig 1B). 
hCOA3-FLAG is not extracted from the 
mitochondrial membrane by sodium 
carbonate treatment, indicating hCOA3 is an 
intrinsic membrane protein, as expected from 
its predicted transmembrane domain (Fig 1B).  
hCOA3-FLAG is protected from 
proteinase K digestion in isolated 
mitochondria, but is partially digested in 
mitoplasts, where the outer membrane is 
disrupted (Fig 1C). Interestingly, anti-hCOA3 
antibodies but not anti-FLAG antibodies 
detect a polypeptide of smaller size in 
mitoplasts treated with proteinase K, probably 
hCOA3 after the FLAG tag has been digested 
(Fig 1C). In addition, hCOA3-FLAG behaves 
as an inner mitochondrial membrane protein 
when the outer mitochondrial membrane is 
solubilized by digitonin treatment (Fig 1D). 
Taken together these data demonstrate that 
hCOA3 is an intrinsic protein of the 
mitochondrial inner membrane with the C-
terminus exposed to the intermembrane space. 
 
hCOA3 is essential for cytochrome c 
oxidase activity and holocomplex 
accumulation 
To characterize the function of 
hCOA3 in human mitochondria, we have 
silenced its expression using short 
interference RNAs (siRNAs). For this 
purpose, three specific siRNAs against 
hCOA3 and a non-interfering control siRNA 
were transiently transfected into HeLa cells. 
Four days after transfection, the cells were 
harvested and analyzed for the activity of the 
OXPHOS complexes (Fig 2A-B) and hCOA3 
mRNA levels using quantitative RT-PCR 
(Fig 2C). hCOA3 interfered cells present a 
specific defect in COX activity, which was 
reduced to 30% of controls, whereas the 
activity of all other respiratory chain 
complexes, as well as citrate synthase 
activity, remained unchanged (Fig 2A-B). 
This decrease in COX activity correlated with 
a similar decrease in the steady-state levels of 
fully assembled complex IV, as observed in 
Blue Native gel electrophoresis (BN-PAGE) 
experiments (Fig 3A). Although our 
extraction conditions (2% dodecyl maltoside, 
DDM) are known to significantly disrupt the 
macromolecular assemblies of respiratory 
chain complexes into supercomplexes (21), 
we were able to also detect a decrease in 
supercomplex CIII/CIV in silenced cells. 
There was a perfect correlation between the 
activity and the levels of fully assembled 
complex in each experiment, suggesting that 
the residual enzyme present in the interfered 
cells is fully active and the respiratory defect 
results from an impairment of COX assembly. 
These data point toward an involvement of 
hCOA3 in COX biogenesis rather than in the 
regulation of its activity. 
We next investigated whether the 
levels of COX structural subunits were also 
affected in hCOA3 knockdown cells. 
Consistently with the COX activity and BN-
PAGE results, we observed hCOA3 interfered 
cells have lower steady-state levels of COX1, 
COX2, COX3 and COX4 subunits while the 
levels of complex I, II, III or V subunits 
remained unchanged when compared to 
controls (Fig 3B). Noticeably, COX5a 
showed almost similar levels in knockdown 
and control cells, suggesting this protein has a 
longer-half life than other COX structural 
subunits. 
 
COX1 is rapidly degraded in hCOA3-
silenced cells 
To systematically investigate the role 
of hCOA3 in COX assembly, we started by 
assessing whether the decrease in COX 
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subunits was due to defective mitochondrial 
transcription. We measured the levels of their 
transcripts using quantitative RT-PCR and 
specific primer pairs for each gene and failed 
to find any differences in steady-state levels 
of COX1, COX2 and COX3 mRNAs or in the 
levels of other mitochondrial mRNAs and 
rRNAs when compared to controls (Fig 4A), 
indicating mitochondrial transcription is not 
affected in the absence of hCOA3.  
We next determined if hCOA3 
interfered cells had altered synthesis or 
turnover rates of any of the mtDNA-encoded 
COX subunits. To this end, we pulse-labeled 
mitochondrial translation products with [35S]-
methionine for 30 minutes in the presence of 
an inhibitor of cytoplasmic translation and the 
labeled polypeptides were subsequently 
chased for 2, 4 or 7 hours. Interfered cells 
showed a specific mild decrease in the 
amount of pulse-labeled COX1, while the rest 
of the mtDNA-encoded polypeptides were 
synthesized at rates similar than in control 
cells (Fig 4B, D). Pulse-chase experiments 
showed newly synthesized COX1 is rapidly 
degraded in hCOA3-deficient cells (Fig 4C, 
E). On the contrary, the stability of COX2, 
COX3 or any other mtDNA-encoded 
polypeptides was not markedly different in 
control and hCOA3-deficient cells during the 
chase periods analyzed (data not shown).  
Even though newly synthesized 
COX2 and COX3 are more stable than 
COX1, western-blot analyses revealed low 
levels of the three catalytic core subunits. The 
three mtDNA-encoded COX subunits are 
preferentially degraded when COX fails to 
assemble and if one of the subunits is 
particularly labile, the other two become also 
unstable (22-24). To clarify whether hCOA3 
plays a role on the stability or biogenesis of 
one or several of the mtDNA-encoded COX 
subunits, we labeled mitochondrial translation 
products for 30 minutes with [35S]-methionine 
and performed immunoprecipitation 
experiments with anti-FLAG antibodies in 
HeLa cells either overexpressing hCOA3-
FLAG or containing an empty pIRESpuro2 
vector. As shown in figure 5 newly 
synthesized COX1 is greatly enriched in the 
eluate from hCOA3-FLAG overexpressing 
cells, demonstrating that hCOA3 interacts 
with newly synthesized COX1 These results 
indicate that hCOA3 is required for COX1 
stability and point towards the loss of COX1 
in hCOA3-depleted cells as the cause of the 
degradation of the remaining COX catalytic 
core subunits. 
 
hCOA3 is a cytochrome c oxidase assembly 
factor 
hCOA3 knockdown induces a rapid 
degradation of the newly synthesized COX1, 
which together with the decreased steady-
state levels of COX2, COX3 and the nuclear 
DNA-encoded subunit COX4, suggest 
hCOA3-silenced cells may have an early 
defect in COX assembly most probably 
involving COX1. To gain insight into how 
COX assembly proceeds in silenced cells we 
depleted the respiratory chain complexes 
using the mitochondrial translation inhibitor 
chloramphenicol, let the cells recover for 48 
hours and performed 2D BN/SDS-PAGE 
experiments to analyze the accumulation and 
distribution of the different subunits in each 
assembly intermediate. As shown in figure 6, 
hCOA3 deficient cells accumulate a 
subassembly intermediate that contains 
COX1, COX4 and COX5a. In the current 
model of human COX assembly, the first 
subassembly (S1) formed during the process 
exclusively contains COX1, which acts as a 
seed for sequential incorporation of COX 
subunits. In this model, the addition of 
subunits COX4 and COX5a to S1 results in 
the progression to the second assembly 
intermediate (S2) (5,25,26). The accumulated 
subassembly in interfered cells corresponds 
with subcomplex S2 and indicates that 
hCOA3 is participating in the early steps of 
COX assembly, most probably facilitating the 
addition of the subsequent COX subunits to 
COX1 containing intermediates. 
 
hCOA3-FLAG overexpression rescues the 
cytochrome c oxidase defect 
To ensure that the defects observed in 
interfered cells were exclusively due to 
hCOA3 silencing, we overexpressed in HeLa 
cells the hCOA3-FLAG construct described 
earlier. This construct does not include the 
3’UTR of hCOA3 mRNA that contains the 
regions of homology of the siRNAs, avoiding 
in this way the RNA interference machinery.  
hCOA3-FLAG overexpression had no 
effect on COX activity or the levels of its 
subunits (Fig 7A, B, C). Nevertheless, 
hCOA3-FLAG overexpression was able to 
fully rescue the COX defect caused by 
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hCOA3 silencing (Fig 7C, D) confirming that 
the previously observed localization of the 
overexpressed protein in the inner 
mitochondrial membrane is correct and the 
absence of hCOA3 is responsible for the 
phenotypes observed in interfered cells. 
 
hCOA3 interacts with COX subunits 
promoting cytochrome c oxidase assembly 
To further investigate the function of 
hCOA3 in the early steps of COX biogenesis 
we asked whether hCOA3 physically interacts 
with COX subassemblies. 2D BN/SDS-PAGE 
analysis of hCOA3-FLAG overexpressing 
cells extracted with 2% DDM revealed that 
hCOA3-FLAG is part of several complexes, 
ranging in size from monomeric hCOA3-
FLAG to almost 1 MDa (Fig 8A), indicating 
its potential interaction with other proteins 
that could constitute COX subassemblies.  
Because the overexpressed FLAG-
tagged version of hCOA3 is fully functional 
and it is forming several high molecular mass 
complexes, we performed 
immunoprecipitation experiments using anti-
FLAG antibodies in overexpressing and 
control cells to identify its binding partners. 
Three independent immunoprecipitation 
experiments followed by mass spectrometry 
analysis identified several COX structural 
subunits present in the eluate, supporting 
previous observations that indicate a role for 
hCOA3 in COX assembly. Moreover, this 
analysis showed hCOA3-FLAG 
coimmunoprecipitates with the mitochondrial 
translation elongation factor Tu (mt-EfTu) 
and SLIRP (stem-loop RNA binding protein), 
both involved in mitochondrial translation 
(Suplementary Table 1).  
To confirm these results, we 
performed additional immunoprecipitation 
experiments followed by immunoblotting 
(Fig 8B). Anti-FLAG antibodies efficiently 
immunoprecipitated COX1 in hCOA3-FLAG 
overexpressing cells. COX structural subunits 
COX2, COX3, COX4 and COX5a are also 
coimmunoprecipitated with hCOA3-FLAG 
although less efficiently than COX1. None of 
these COX subunits were detected in the 
eluate of control cells either using mass 
spectrometry or western blot analysis. 
Western-blot experiments also confirmed mt-
EFTu coimmunoprecipitates with hCOA3-
FLAG but showed a weak 
coimmunoprecipitation of SLIRP and 
hCOA3-FLAG (Fig 8B). SLIRP forms a 
ribonucleoprotein complex with LRPPRC, a 
protein involved in the stabilization and 
polyadenylation of mitochondrial mRNAs 
(27-29). LRPPRC however was barely 
detected in the eluate of hCOA3-FLAG 
overexpressing cells. To confirm these 
results, mitochondria from hCOA3-FLAG 
overexpressing cells were lysed using the 
milder detergent digitonin (1%). Neither 
SLIRP nor LRPPRC were specifically 
recovered after immunoprecipitation using 
anti-FLAG antibodies (Fig 8C), thus 
suggesting that these proteins do not form a 
stable complex.  
Our mass spec analyses of hCOA3-
FLAG eluates also detected several 
mitochondrial import receptors, namely the 
translocase of the inner membrane (TIM) 
proteins TIM22, TIM13, TIM23 and TIM23B 
(Supplementary Table 1). These results are 
relevant because during the preparation of the 
revised version of this manuscript it has been 
reported that TIM21, a component of the 
TIM23 transport machinery, is also present in 
respiratory chain subassemblies containing 
newly mitochondria-synthesized and 
imported respiratory-chain subunits as well as 
some assembly factors such as CCDC56 (30). 
The authors have proposed that in this way, 
the transfer of newly imported proteins from 
the presequence translocase is coordinated 
with the assembly of respiratory-chain 
complexes (30).  
Focusing on respiratory chain 
complex subunits, when the extraction was 
performed with DDM, the CII 70KDa 
(complex II) or CIII Core2 (complex III) 
subunits were not immunoprecipitated using 
anti-FLAG antibodies in hCOA3-FLAG 
overexpressing cells, perhaps because the low 
abundance of the CIII-CIV supercomplex 
under these extraction conditions. 
Interestingly however, mass spectrometry 
results revealed the presence of several 
complex I (CI) subunits in the eluate 
(Supplementary Table 1) and immunoblot 
experiments confirmed the interaction of 
hCOA3 with NDUFA9 and NDUFV1, thus 
suggesting an early interaction of complex I 
subunits with COX assembly intermediates as 
recently reported (31). The same subunits 
were detected in hCOA3-FLAG 
immunoprecipitates from digitonin extracts 
(Fig 8C). However, not all complex I 
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subunits analyzed were recovered in the 
immunoprecipitate (see NDUFS1 in Fig 8B), 
further supporting the concept that the 
interaction between complex I and complex 
IV subunits occurs before the complexes are 
fully assembled. 
 
DISCUSSION 
CCDC56 was recently identified by 
our group as a new protein essential for 
cytochrome c oxidase activity in Drosophila 
melanogaster, although its precise function 
remained to be elucidated (20). In this study, 
we have identified and characterized the 
function of the human homologue of 
CCDC56. Our results show human CCDC56 
participates in the early steps of the assembly 
of the holoenzyme by promoting nascent 
COX1 stability and facilitating its assembly 
with other COX subunits, confirming the 
results by Szklarczyk and collaborators who 
proposed CCDC56 to be the human 
homologue of yeast Coa3 (18) and therefore 
the protein has been termed hCOA3.  
hCOA3 is located on chromosome 
17 (17q.21.31) and encodes an 11.7 KDa 
transmembrane protein of the inner 
mitochondrial membrane with a coiled coil 
domain in its C-terminus facing the 
intermembrane space. hCOA3-silenced cells 
present a severe defect in COX activity and a 
similar decrease in the levels of fully 
assembled complex. These data, together with 
the decrease in the steady-state levels of 
several COX subunits in silenced cells, 
pointed toward an involvement of hCOA3 in 
COX biogenesis. Silenced cells presented a 
mild but specific decrease in the amount of 
pulse-labeled COX1, suggesting its 
translation could be impaired in the absence 
of hCOA3. However, newly synthesized 
COX1 was rapidly degraded in interfered 
cells, indicating that the observed decrease in 
COX1 labeling could be due to increased 
degradation of the newly synthesized 
polypeptide rather than to defective 
translation. Synthesis of COX2 and COX3 
and their stability over a 7 hour chase were as 
in wild-type cells. Although these subunits 
have a longer half-life than COX1, they are 
known to be unstable when COX assembly is 
compromised (22,32) and, accordingly, their 
steady-state levels in hCOA3 interfered cells 
were markedly lowered. 
COX assembly is a linear process in 
which at least three subassemblies, S1, S2 and 
S3, can be detected, which probably represent 
the rate-limiting steps of the process (5). In 
this model, originally proposed by Nijtmans 
et al. (5), S1 is formed exclusively by COX1, 
and the addition of subunits COX4 and 
COX5a to S1 results in the progression to S2. 
We have observed that hCOA3-silenced cells 
presented accumulates of an assembly 
intermediate that contains COX1, COX4 and 
COX5a and corresponds to the S2 
subassembly. The accumulation of this 
intermediate, however, is not very prominent 
probably due to remaining amounts of 
hCOA3 in silenced cells that allow COX 
assembly to proceed, resulting in the residual 
amounts of fully assembled holoenzyme 
observed in BN-PAGE experiments.  
A similar subassembly has been 
reported to accumulate in cells from patients 
suffering from mitochondrial diseases due to 
mutations in several COX assembly genes. 
For example, SCO1 and SCO2 mutant 
fibroblasts, both of which are required for 
COX2 maturation, accumulate the S2 
intermediate (25,33). In the hCOA3-silenced 
cells, the accumulation of the S2 intermediate 
indicates hCOA3 is a COX assembly factor 
involved in the first steps of the assembly 
process, probably facilitating the 
incorporation of COX subunits to COX1-
containing intermediates. 
We have observed hCOA3-FLAG is 
forming several high molecular weight 
complexes, which could constitute COX 
subassemblies as well as CIII/CIV 
supercomplexes, as has already been observed 
for its yeast homologue Coa3 (34,35). The 
physical interaction with COX subunits was 
demonstrated by immunoprecipitation studies 
followed by mass spectrometric and 
immunoblot analyses. Interestingly, these 
analyses also showed hCOA3 interacts with 
some complex I subunits such as NDUFA9 
and NDUFV1 but not others such as 
NDUFS1. It has been recently reported that 
complex I assembly takes place in the context 
of supercomplexes or respirasomes (22) 
which could explain the interaction between 
COX and complex I assembly intermediates.  
Because COX contains highly 
reactive heme A and copper prosthetic 
groups, the biogenesis of this enzyme must be 
tightly regulated to prevent the accumulation 
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of pro-oxidant assembly intermediates. 
Coordination of COX1 synthesis and COX 
assembly has been extensively studied in S. 
cerevisiae. Mss51, the central protein of a 
negative feedback translational regulatory 
system in yeast, has a dual function acting as 
a translational activator of COX1 mRNA and 
as a COX1 chaperone during the first steps of 
COX biogenesis (36). During and after 
synthesis, COX1 is bound to Mss51 in a 
complex stabilized by two small COX-
specific chaperones, Cox14 (37) and Coa3 
(34,35) and the mitochondrial Hsp70 
chaperone (38). When COX1 proceeds in the 
assembly process, Mss51 is released from 
these complexes and is available to activate 
new rounds of Cox1 synthesis (38-40). 
For many years, the translational 
regulatory system was believed to be 
restricted to yeast because homologues of 
Mss51, Cox14 and Coa3 had not been 
identified. However, the recent discovery that 
the three proteins are conserved in humans 
opened the possibility that such a regulatory 
system could have been also conserved. So 
far, the human homologues of Cox14 
(C12orf62; (19)) and Coa3 
(CCDC56/hCOA3; this work) have been 
shown to be COX assembly factors important 
for COX1 stability and assembly, similar to 
their yeast counterparts. Our mass 
spectrometry studies failed to detect C12orf62 
as an hCOA3 interactor, although this could 
perhaps be justified by the small size of the 
protein (~15 kDa). Importantly, our 
immunoprecipitation results have suggested 
hCOA3 interacts with mt-EfTu. A similar 
interaction was previously described for 
C12orf62 (19). hCOA3 interaction with 
newly synthesized COX1 and proteins 
involved in translation, together with our 
pulse-labeling results, could reflect an early 
interaction of hCOA3 with COX1 during 
translation, required to stabilize the protein 
and prevent its degradation. mt-EfTu, 
although primarily acts as a mitochondrial 
translation elongation factor, can also 
function as a chaperone promoting the folding 
of newly synthesized polypeptides (41) and 
could therefore have a role in quality control 
of the nascent COX enzyme subunits and 
assembly intermediates through the binding 
of C12orf62 and hCOA3. It is conceivable 
that hCOA3 interacts early with newly 
synthesized COX1 polypeptide, perhaps 
during its elongation following its co-
translational membrane insertion. Altogether, 
our results support that hCOA3 associates 
directly or indirectly with the COX1 mRNA 
translational machinery and interacts with the 
newly synthesized polypeptide providing 
stability and facilitating its assembly with 
other COX subunits to form the mature 
holoenzyme.  
Finally, the identification of hCOA3 
as a new COX assembly factor in humans is 
not only relevant from a biological point of 
view but also from a biomedical perspective. 
Most isolated COX deficiencies described to 
date in patients with mitochondrial diseases 
are caused by mutations in COX assembly 
factors, rather than mutations in structural 
subunits of the complex. Expanding the list of 
COX assembly factors responsible for human 
diseases, a recent report has identified 
mutations in c12orf62 in a patient with fatal 
neonatal lactic acidosis (19). Our data 
indicates that hCOA3 is a new candidate gene 
to screen in patients suffering from 
mitochondrial diseases associated with 
isolated COX deficiency. Increasing our 
knowledge of COX biogenesis and its 
regulation is expected to contribute to our 
understanding of mechanisms underlying 
these disorders. 
 
EXPERIMENTAL PROCEDURES 
siRNAs, Taqman Probes and constructs 
Three Silencer Select pre-designed siRNAs 
against hCOA3 (s26294, s26295, s26296), 
siRNA Silencer negative control #2 (Ki #2) 
and Taqman assays for CCDC56 mRNA 
(Hs00360235_m1) and 18S rRNA 
(Hs99999901_s1) were purchased from 
Applied Biosystems. 
For the FLAG-tagged hCOA3 construct, 
hCOA3 cDNA was amplified using the cDNA 
clone BX280424 (ImaGenes) as a template, 
with specific primers carrying in frame the 
FLAG tag and recognition sites for AflII and 
NotI respectively 
(5’TTCTTAAGATGGCGTCTTCGGGAGCT
GGTG3’, 
5’ATGCGGCCGCTTACTTGTCGTCATCG
TCTTTGTAGTCGGACCCTGACGCCCTT
GCCAGAGCTCG3’). The PCR product was 
digested and cloned into pIRESpuro2 
(Clontech). Fidelity of the clones was 
confirmed by sequencing. 
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Antibodies 
To express hCOA3 in E. coli a PCR fragment 
encoding the full hCOA3 cDNA was cloned 
in pRSET-B (Invitrogen, Life Technologies). 
Polyclonal antibody was generated using 
standard procedures. Polyclonal antibody 
anti-MnSOD was obtained from Millipore. 
Monoclonal antibodies against COX1, COX2, 
COX3, COX4, COX5a, NDUFA9 and Porin 
were purchased from Mitosciences. 
Monoclonal antibodies against CII 70KDa 
and CIII Core2 and secondary antibody 
coupled to Alexa Fluor 488 were purchased 
from Molecular Probes (Invitrogen, Life 
Sciences). Anti-FLAG M2 monoclonal 
antibody was obtained from Stratagene. Anti-
SLIRP, anti-mt-EFTu, anti-LRPPRC, anti-
NDUFV1 and anti-NDUFS1 antibodies were 
obtained from Abcam. Secondary antibodies 
coupled to horseradish peroxidase were 
obtained from Santa Cruz Biotechnology. 
Anti-βATPase polyclonal antibodies had been 
previously generated in the lab (42). 
 
Cell lines, cell culture and transfection 
HeLa cells were cultured in high-glucose 
DMEM (Invitrogen, Life Technologies) 
supplemented with 10% fetal bovine serum, 
uridine and antibiotics at 37ºC in a 5% CO2 
atmosphere. Cells were transfected with 30 
nM siRNAs or 5 µg of the constructs using 
Lipofectamine 2000 (Invitrogen, Life 
Technologies) following the manufacturer’s 
instructions. For hCOA3 silencing 
experiments cells were harvested 96 hours 
after transfection. To generate the cell lines 
stably overexpressing hCOA3-FLAG, 1.5 
µg/ml of puromycin were added to the 
medium two days after transfection. The 
resultant cell line was grown in the presence 
of the antibiotic. 
 
Mitochondrial subfractionation and 
proteinase K protection assays 
Mitochondria were purified from HeLa cells 
expressing hCOA3-FLAG as previously 
described (20). Mitochondria were ruptured 
by sonication. Soluble and insoluble fractions 
were obtained by centrifugation at 50000 g 
for 15 minutes at 4°C. The membrane pellet 
was resuspended in 0.1 M Na2CO3, pH 11. 
After 30 min on ice, the sample was 
centrifuged at 50000 g for 15 minutes at 4°C 
to separate the soluble membrane extrinsic 
from the insoluble intrinsic membrane 
proteins. 
Purified mitochondria from hCOA3-FLAG 
were resuspended in 10 mM TrisHCl pH 7, 
10 mM KCl, 0.15 mM MgSO4 buffer either 
containing 0.25 M sucrose or devoid of 
sucrose to allow mitochondria swelling and 
conversion to mitoplasts. Samples were 
treated where indicated with 0.62 µg/ml 
proteinase K for 20 minutes in ice. 
Mitochondria and mitoplasts were recovered 
by centrifugation at 50,000 g for 15 min at 
4°C and analyzed by Western blotting. 
To selectively solubilize the outer 
mitochondrial membrane, purified 
mitochondria from hCOA3-FLAG 
overexpressing cells were resuspended in 10 
mM Tris-HCl pH 7, 10 mM KCl, 0.15 mM 
MgSO4, 0.25 M sucrose buffer and treated 
with 1% digitonin for 30 min in ice. 
Membranes and the soluble fraction were 
separated by centrifugation at 50,000 g for 15 
min at 4°C and analyzed by Western blotting. 
 
Activity of the OXPHOS complexes 
The activity of the OXPHOS complexes and 
the enzyme citrate synthase were determined 
as previously described (20). 
 
BN-PAGE and 2D BN/SDS-PAGE 
Blue Native electrophoresis and second-
dimension BN/SDS electrophoresis of the 
OXPHOS complexes was performed as 
previously described (43). For 2D BN/SDS-
PAGE experiments, transfected cells were 
treated with 10 µg/ml chloramphenicol for 
two days to deplete the respiratory chain 
complexes and retransfected with siRNAs 48 
hours after the first transfection. Cells were 
collected at 96 hours of hCOA3 interference 
and 48 hours of recovery after 
chloramphenicol treatment. 
 
Pulse labeling of mitochondrial translation 
products 
In vivo labeling of the mitochondrial 
translation products was performed as 
previously described (44). Briefly, cells were 
labeled for 30 minutes in 
methionine/cysteine-free DMEM containing 
200 µCi/ml of [35S]-Methionine (Perkin 
Elmer) and 100 µg/ml of either emetine 
(pulse experiments) or anisomycin (pulse-
chase experiments). After the incubation, 
cells were washed and harvested (pulse) or 
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incubated in regular DMEM for 2, 4 and 7 
hours (chase). 100 µg of whole protein 
extracts were loaded on 15-20% SDS-PAGE 
gradient gels and the labeled mitochondrial 
translation products were detected through 
direct autoradiography or quantified using a 
Typhoon phosphorimager system (GE 
Healthcare). 
 
Immunocytochemistry 
HeLa cells expressing hCOA3-Flag were 
plated on coverslips and grown overnight at 
37ºC. Cells were stained for 30 minutes with 
50 nM Mitotracker red (Molecular Probes, 
Invitrogen), fixed with 2% PFA and treated 
with methanol before the incubation with an 
anti-Flag primary antibody (Stratagene) in 2% 
BSA. Secondary antibody Alexa Fluor 488 
(Molecular Probes, Invitrogen) was used for 
immunofluorescence detection. 
 
Immunoprecipitation 
Mitochondria were purified from HeLa cells 
expressing hCOA3-FLAG or containing 
empty pIRESpuro2 vector as previously 
described (20). Equal amounts of 
mitochondrial protein of each cell line were 
lysed using 1% DDM in 50 mM Tris HCl pH 
7.4, 150 mM NaCl and 1 mM EDTA. 
hCOA3-FLAG was immunoprecipitated 
using FLAG Immunoprecipitation Kit 
(Sigma-Aldrich) following manufacturer’s 
instructions. Proteins were eluted using a 
FLAG peptide and analyzed though mass 
spectrometry and immunoblotting.  
The proteomics analysis was carried out in 
the ‘CBMSO PROTEIN CHEMISTRY 
FACILITY’, a member of ProteoRed 
network. Protein extracts were applied onto a 
SDS-PAGE gel and the run was stopped as 
soon as the front entered into the resolving 
gel. The unseparated protein bands were 
visualized by Coomassie staining, excised, 
destained in acetonitrile:water (1:1) And 
digested in situ with sequencing grade trypsin 
as described by Shevchenko et al. (45) with 
minor modifications. The dried gel pieces 
were re-swollen in 50 mM ammonium 
bicarbonate with 60 ng/µl trypsin (Promega) 
at a 5:1 protein:trypsin (w/w) ratio in 50 mM 
ammonium bicarbonate, pH 8.8. The tubes 
were kept in ice for 2 h and incubated at 37°C 
for 12 h. Whole supernatants were dried down 
and desalted onto Omix tips. The desalted 
protein digest was dried, resuspended in 0.1% 
formic acid and analyzed by reverse phase-
liquid chromatography-MS/MS (RP-LC-
MS/MS) in an Agilent 1100 system coupled 
to a linear ion trap LTQ-Velos mass 
spectrometer (Thermo Fisher Scientific). 
Peptides were detected in survey scans from 
400 to 1600 amu (1 µscan), followed by 15 
data dependent MS/MS scans (Top 15), using 
an isolation width of 2 u (mass-to-charge ratio 
units), normalized collision energy of 35%, 
and dynamic exclusion applied during 30 
second periods. Peptide identification from 
raw data was carried out using the SEQUEST 
algorithm (Proteome Discoverer 1.3, Thermo 
Fisher Scientific). Database search was 
performed against uniprot-homo.fasta. The 
following constraints were used for the 
searches: tryptic cleavage after Arg and Lys, 
up to two missed cleavage sites, and 
tolerances of 1 Da for precursor ions and 0.8 
Da for MS/MS fragment ions and the 
searches were performed allowing optional 
Met oxidation and Cys 
carbamidomethylation. Search against decoy 
database (integrated decoy approach) was 
performed using false discovery rate (FDR) < 
0.01. 
 
Statistical analysis 
Graphs represent mean values of at least three 
independent measurements. Error bars 
represent standard deviations (SD). One-way 
or two-way ANOVA were performed using 
GraphPad Prism version 4.00 for Windows, 
GraphPad Software, San Diego, California 
USA, www.graphpad.com. 
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LEGENDS TO FIGURES 
Figure 1. hCOA3 is a transmembrane protein of the inner mitochondrial membrane. (A) 
Immunocytochemistry of HeLa cells overexpressing hCOA3-FLAG (hCOA3-FLAG). 
hCOA3-FLAG was visualized using anti-FLAG M2 antibodies. Mitochondria were stained 
using Mitotracker Red. Images were analyzed in a Carl Zeiss confocal microscope, objective 
40x. Bars represent 10 µm. (B) Purified mitochondria from hCOA3-FLAG overexpressing 
cells (hCOA3-FLAG) were sonically irradiated and centrifuged to separate the soluble (S) 
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and membrane proteins. The membrane pellet was treated with 0.1 M Na2CO3 and 
centrifuged to separate the soluble membrane extrinsic (CS) from the insoluble intrinsic 
membrane proteins (P). Equivalent volumes of each fraction were analyzed by Western 
blotting. (C) Mitochondria (Mc) and mitoplasts (Mp) from hCOA3-FLAG overexpressing 
cells were treated with proteinase K where indicated. After proteinase K treatment, 
mitochondria and mitoplasts were recovered by centrifugation and analyzed by Western 
blotting. (D) Purified mitochondria from hCOA3-FLAG overexpressing cells were treated 
with 1% digitonin to selectively solubilize the mitochondrial outer membrane. Membranes (P) 
and the soluble fraction (S) were separated by centrifugation and analyzed by Western 
blotting. 0.5, 1, 2 and 3 times of equivalent soluble fraction were loaded on the gel. 
 
Figure 2. hCOA3 knockdown causes a defect in COX activity in HeLa cells. (A) Specific 
activity of the OXPHOS complexes. (B) Citrate synthase specific activity. (C) Quantitative 
RT-PCR of hCOA3 mRNA. All experiments were performed in untransfected HeLa cells 
(Untransfected), HeLa cells transfected with non-interfering siRNAs (Ki #2) or siRNAs 
against hCOA3 (siRNAs hCOA3) 96 hours after transfection. Data represent mean values ± 
SD, *** p<0.001, n=6. 
 
Figure 3. hCOA3 knockdown causes a decrease of fully assembled COX in HeLa cells. 
BN-PAGE of the OXPHOS complexes (A) and steady-state levels of the OXPHOS subunits 
analyzed by Western-Blotting (B) in untransfected HeLa cells (Untransfected), HeLa cells 
transfected with non-interfering siRNAs (Ki #2) or siRNAs against hCOA3 (siRNAs 
CCDC56) 96 hours after transfection.  
 
Figure 4. hCOA3 knockdown induces a rapid degradation of the newly synthesized 
COX1. (A) Quantitative RT-PCR of mitochondrial mRNAs (left panel) and hCOA3 mRNA 
(right panel) in untransfected HeLa cells (Untransfected), HeLa cells transfected with non-
interfering siRNAs (Ki #2) or siRNAs against hCOA3 (siRNAs hCOA3) 96 hours after 
transfection. Data represent mean values ± SD, *** p<0.001, n=5. (B) Newly synthesized 
mitochondrial polypeptides were labeled with [S35]-methionine for 30 minutes. Mitochondrial 
translation products were detected through direct autoradiography of the gels. (C) Newly 
synthesized mitochondrial polypeptides were labeled with [S35]-methionine for 30 minutes. 
Cells were then washed and incubated in regular DMEM for 2, 4 or 7 hours. Mitochondrial 
translation products were detected through direct autoradiography of the gels. (D) 
Quantification of COX1 labeling in pulse experiments. Data represent mean values ± SD, ** 
p<0.01, n=4. (E) Quantification of COX1 labeling in pulse-chase experiments. Data represent 
mean values ± SD, * p<0.05, ** p<0.01, n=4. 
 
Figure 5. hCOA3 interacts with newly synthesized COX1. In vivo labeling of 
mitochondrial translation products followed by immunoprecipitation using anti-FLAG M2 
antibodies in HeLa cells containing pIRESpuro2 (pIRESpuro2) and HeLa cells stably 
overexpressing hCOA3-FLAG (hCOA3-FLAG). 10% of the corresponding volume of input, 
unbound and wash fractions was loaded on the gels. 
 
Figure 6. hCOA3 knockdown causes a defect in cytochrome c oxidase assembly. (A) 2D 
BN/SDS-PAGE of the OXPHOS complexes in untransfected HeLa cells (Untransfected), 
HeLa cells transfected with non-interfering siRNAs (Ki #2) or siRNAs against hCOA3 
(siRNAs hCOA3). S1, S2 and S3 indicate the three COX subassemblies, S4 indicates the 
COX monomer and CIII+IV indicates supercomplex III+IV. Black circle indicates the 
accumulation of a COX4 containing assembly intermediate in interfered cells. (B) 
Quantitative RT-PCR of hCOA3 mRNA. Experiments were performed in untransfected HeLa 
cells (Untransfected), HeLa cells transfected with non-interfering siRNAs (Ki #2) or siRNAs 
against hCOA3 (siRNAs hCOA3) 96 hours after transfection. Data represent mean values ± 
SD, *** p<0.001, n=4. 
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Figure 7. hCOA3-FLAG overexpression fully rescues COX defect in interfered cells. (A) 
COX activity (left panel), citrate synthase activity (middle panel) and quantitative RT-PCR of 
hCOA3 mRNA (right panel) in HeLa cells (HeLa), HeLa cells containing empty pIRESpuro2 
vector (pIRESpuro2) and HeLa cells stably overexpressing hCOA3-FLAG (hCOA3-FLAG). 
Data represent mean values ± SD, *** p<0.001, n=4. (B) BN-PAGE of the OXPHOS 
complexes in HeLa cells (HeLa), HeLa cells containing empty pIRESpuro2 vector 
(pIRESpuro2) and HeLa cells stably overexpressing hCOA3-FLAG (hCOA3-FLAG). (C) 
Steady-state levels of the OXPHOS subunits analyzed by Western-Blotting in HeLa cells 
(HeLa), HeLa cells containing empty pIRESpuro2 vector (pIRESpuro2) and HeLa cells stably 
overexpressing hCOA3-FLAG (hCOA3-FLAG). (D) COX specific activity and (E) hCOA3 
mRNA levels in HeLa cells (HeLa), HeLa cells containing pIRESpuro2 (pIRESpuro2) and 
HeLa cells stably overexpressing hCOA3-FLAG (hCOA3-FLAG). Each cell line was 
transiently transfected with non-interfering siRNAs (Ki #2) and siRNAs against hCOA3 
(siRNAs hCOA3). COX activity and hCOA3 mRNA were measured 96 hours after 
transfection. Data represent mean values ± SD, *** p<0.001, n=3. 
 
Figure 8. hCOA3 interacts with COX structural subunits and complex I. (A) 2D 
BN/SDS-PAGE of hCOA3-FLAG overexpressing HeLa cells. S1, S2 and S3 indicate the 
three COX subassemblies, S4 indicates the COX monomer and CIII+IV indicates 
supercomplex III+IV. (B) Immunoprecipitation using anti-FLAG M2 antibodies in control 
(pIRESpuro2) and hCOA3-FLAG overexpressing (hCOA3-FLAG) mitochondria. Proteins 
were extracted with 1% DDM. 10% of the corresponding volume of input, unbound and wash 
fractions was loaded on the gels. (C) Proteins were extracted from isolated mitochondria from 
HeLa cells and HeLa cells overexpressing hCOA3-FLAG with 1% digitonin. Extracts were 
incubated with protein A sepharose beads and anti-FLAG antibodies where indicated. Beads 
and supernatant were recovered by centrifugation. Samples were analyzed by Western 
blotting. 
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